Sihuan Pharmaceutical Holdings
Sihuan Pharmaceutical Holdings Group Ltd, commonly referred to as Sihuan Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Beijing, China. Founded in 2001, the company has established itself as a leader in the development, manufacturing, and marketing of innovative pharmaceutical products, particularly in the fields of cardiovascular and central nervous system therapies. With a strong operational presence across major regions in China, Sihuan Pharmaceutical is renowned for its unique portfolio of prescription drugs and over-the-counter products. The company has achieved significant milestones, including the successful launch of several key medications that address critical health needs. Sihuan Pharmaceutical's commitment to research and development, coupled with its strategic market positioning, has garnered recognition within the industry, solidifying its reputation as a trusted provider of high-quality healthcare solutions.
DitchCarbon Score
How does Sihuan Pharmaceutical Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sihuan Pharmaceutical Holdings's score of 25 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sihuan Pharmaceutical Holdings's reported carbon emissions
In 2023, Sihuan Pharmaceutical Holdings reported total carbon emissions of approximately 104,067,670 kg CO2e, with Scope 1 emissions at about 45,601,810 kg CO2e and Scope 2 emissions at around 58,465,860 kg CO2e. This marks a slight decrease from 2022, where total emissions were approximately 123,292,250 kg CO2e, with Scope 1 and Scope 2 emissions of about 52,191,660 kg CO2e and 71,100,590 kg CO2e, respectively. The company has disclosed emissions data for Scopes 1 and 2 for the years 2018 through 2023, but there are no specific reduction targets or initiatives outlined in their climate commitments. The absence of documented reduction targets suggests that while Sihuan Pharmaceutical is tracking its emissions, it may not yet have formalised strategies for significant reductions in line with industry standards. Overall, Sihuan Pharmaceutical Holdings is actively monitoring its carbon footprint, but further commitments and initiatives may be necessary to align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 55,110,200 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 36,269,100 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 482,200 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sihuan Pharmaceutical Holdings is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
